Opus Genetics, Inc.
IRD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $30,321 | $50,501 | $42,634 | $24,534 |
| Short-Term Investments | $2 | $15 | $49 | $219 |
| Receivables | $5,772 | $2,333 | $4,850 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $515 | $1,099 | $1,453 | $1,314 |
| Total Curr. Assets | $36,610 | $53,948 | $48,986 | $26,067 |
| Property Plant & Equip (Net) | $252 | $0 | $6 | $10 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $252 | $0 | $6 | $10 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $36,862 | $53,948 | $48,992 | $26,077 |
| Liabilities | – | – | – | – |
| Payables | $3,148 | $2,153 | $1,069 | $1,584 |
| Short-Term Debt | $0 | $0 | $0 | $538 |
| Tax Payable | $0 | $0 | $315 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8,147 | $1,889 | $1,369 | $1,733 |
| Total Curr. Liab. | $11,295 | $4,042 | $2,753 | $3,855 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $18,843 | $0 | $0 | $0 |
| Total NC Liab. | $18,843 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $30,138 | $4,042 | $2,753 | $3,855 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $2 | $2 | $2 |
| Retained Earnings | -$138,998 | -$81,466 | -$71,480 | -$89,368 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $145,719 | $131,370 | $117,717 | $111,588 |
| Total Equity | $6,724 | $49,906 | $46,239 | $22,222 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $36,862 | $53,948 | $48,992 | $26,077 |
| Net Debt | -$30,321 | -$50,501 | -$42,634 | -$23,996 |